# AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study

> **NCT00589303** · PHASE3 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 27 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Failure

## Interventions

- **DRUG:** FDA approved rate and rhythm control drugs
- **DEVICE:** AV Node ablation and device implant

## Key facts

- **NCT ID:** NCT00589303
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00589303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00589303, "AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00589303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*